We are live on ! Find out more
AFM

Anson Funds Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 370.24%
This Fund
S&P 500
This Quarter Est. Return
+2.27%
1 Year Est. Return
+370.24%
3 Year Est. Return
+1,243.07%
5 Year Est. Return
+867.54%
10 Year Est. Return
+12,575.88%
AUM
$241M
AUM Growth
-$78.9M
Cap. Flow
-$81.4M
Cap. Flow %
-33.81%
Top 10 Hldgs %
74.61%
Holding
103
New
15
Increased
12
Reduced
10
Closed
54

Top Buys

Rank Stock Value
1
M icon
Macy's
M
+$24.4M
2
BAC icon
Bank of America
BAC
+$9.49M
3
VMC icon
Vulcan Materials
VMC
+$6.13M
4
CMG icon
Chipotle Mexican Grill
CMG
+$4.62M
5
CSX icon
CSX Corp
CSX
+$2.9M

Sector Composition

Rank Sector Weight
1 Financials 17.07%
2 Consumer Discretionary 16.42%
3 Materials 10.57%
4 Technology 8.92%
5 Energy 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHIPW
26
DELISTED
Seanergy Maritime Holdings Corp Class A Warrants
SHIPW
$1.18M 0.49%
+1,432,500
New +$342K
UUUU.WS
27
DELISTED
Energy Fuels Inc.
UUUU.WS
$973K 0.4%
+339,067
New +$399K
CBMXW
28
DELISTED
CombiMatrix Corporation Warrant
CBMXW
$625K 0.26%
114,738
-8,500
-7% -$7.57K
GCVRZ
29
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$556K 0.23%
+1,236,213
New +$543K
NXTDW
30
DELISTED
Nxt-ID, Inc.
NXTDW
$499K 0.21%
269,900
TOON icon
31
Kartoon Studios
TOON
$34.9M
$495K 0.21%
+13,229
New +$592K
VISL
32
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$404K 0.17%
+208
New +$428K
IMUC.WS
33
DELISTED
ImmunoCellular Therapeutics Ltd.
IMUC.WS
$373K 0.15%
117,188
APOPW
34
DELISTED
Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
$346K 0.14%
40,239
-73,108
-64% -$75K
AFMD
35
DELISTED
Affimed
AFMD
$323K 0.13%
14,050
-22,266
-61% -$490K
EDSA icon
36
Edesa Biotech
EDSA
$51.5M
$300K 0.12%
+627
New +$333K
ONTXW
37
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$285K 0.12%
93,750
VANI icon
38
Vivani Medical
VANI
$112M
$277K 0.12%
9,545
+8,249
+636% +$316K
ANY icon
39
Sphere 3D
ANY
$14.9M
$275K 0.11%
+91
New +$381K
AUPH icon
40
Aurinia Pharmaceuticals
AUPH
$1.96B
$250K 0.1%
29,900
-358,108
-92% -$1.65M
HBM.WS
41
DELISTED
Hudbay Minerals Inc.
HBM.WS
$227K 0.09%
+26,000
New +$15.5K
NOVN
42
DELISTED
Novan, Inc. Common Stock
NOVN
$191K 0.08%
3,000
-1,099
-27% -$114K
LITS
43
Lite Strategy Inc
LITS
$33.2M
$138K 0.06%
4,250
-64,093
-94% -$2.06M
CVM icon
44
CEL-SCI Corp
CVM
$20.6M
$64K 0.03%
+997
New +$79.6K
MPVD
45
DELISTED
Mountain Province Diamonds Inc.
MPVD
$64K 0.03%
13,500
-18,200
-57% -$78.6K
NSPR icon
46
InspireMD
NSPR
$32.3M
$62K 0.03%
+2
New +$107K
ABUS icon
47
Arbutus Biopharma
ABUS
$871M
-105,085
Closed -$257K
ADAP
48
DELISTED
Adaptimmune Therapeutics
ADAP
-103,282
Closed -$418K
ADVM
49
DELISTED
Adverum Biotechnologies
ADVM
-12,854
Closed -$373K
AMZN icon
50
PUT
Amazon
AMZN
$2.49T
-1,200,000
Closed -$45M

Similar funds

Anson Funds Management's Q1 2017 Portfolio in Review

As of Q1 2017, Anson Funds Management held 103 positions worth $241M, down 25% from $320M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Anson Funds Management withdrew a net $81.4M in Q1 2017, closing 54 positions and reducing 10 holdings. Its most notable exit was Teekay, an estimated $6.13M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Materials.

Against the trend, Anson Funds Management opened a new position in Macy's worth $23.4M.

  • Anson Funds Management's largest Q1 2017 buy was Macy's: 791,000 shares worth $23.4M.
  • Anson Funds Management added most to Bank of America in Q1 2017, an estimated $9.49M increase.
  • Anson Funds Management's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $12.1M.
  • Anson Funds Management fully exited Teekay in Q1 2017, selling an estimated $6.13M.
  • Anson Funds Management's ten largest holdings make up 75% of its $241M portfolio in Q1 2017.
  • Anson Funds Management opened 15 new positions and closed 54 in Q1 2017.
  • Anson Funds Management's portfolio value fell 25% quarter-over-quarter to $241M.

Based on Anson Funds Management's 13F filing for Q1 2017, filed 15 May 2017.